Our mission is to power your mission
Yendou is a pioneering data management and workflow automation platform for Clinical Operations Teams in the Life Sciences. Our mission is to innovate and develop cutting-edge technologies that empower Life Sciences companies to accelerate the delivery of life-saving therapeutics to patients worldwide.
“Our clients’ work ensure the health of humanity. In making them faster, more productive, and more secure, we don’t just make the business of drug development work better. We make the world healthier. ”
Zina Sarif
Board Director and CEO
Yendou
Our Team
Hi! I'm a former biochemist with over a decade of experience in cancer drug discovery, followed by three years in clinical research finance management at Parexel. Subsequently, I led feasibility and study startup activities for Phase III breast cancer studies at AstraZeneca.
I've always dreamed of a cancer-free world. Yendou is here to turn that dream into reality by accelerating your research.
Patrick, a seasoned Computer Scientist, is not one to introduce himself. People often whisper in awe, "This guy worked for Citadel! Only geniuses get there." He doesn't see what the fuss is about. He worked with top talent at leading companies like Google, and AWS too. Now, his focus is on clinical trials. Whenever you use Yendou, know that Patrick is the wizard behind its magic.
Otis, with over 15 years of experience, has been Vice President of Strategic Feasibility at ICON, Syneos Health, and Merck, and VP of Product at Clario. His expertise extends to Site Selection and Managing Director at Trial Equity, a DEI program for Clinical Research teams. Recently, he became the first person of color to win the HBA DEI ally award at JPM24.
Our 5 Years Mission for the Future of DrugDev
In the past 50 years, there has been enormous innovation in the world of bits. Yet, not in the world of genome. Although innovation in medicine and biotechnology hasn't stalled, it hasn't progressed rapidly either.
Consider clinical trials. Despite being pivotal in the war against diseases, now stretch over 12 years and cost an astronomical $1.2 billion each. This isn't just a financial burden; it's a delay in delivering lifesaving care.
But why should this matter to you? Because while we're advancing in technology, we're lagging in extending human life. The U.S. life expectancy has decreased by 2 years from 2018 to 2022. Non-aging related diseases claim 70% of global deaths.
This isn't just a challenge; it's an opportunity—an opportunity for a leap in healthcare, for a breakthrough in how we develop therapeutics to fight diseases.
At Yendou, we say yes to the challenge and to the opportunity.
Our mission is to supercharge the operational productivity of life sciences companies, enabling them to bring medical innovations to market faster and more efficiently.
Our technologies are designed to streamline clinical trial processes, reduce development costs, and shorten timeframes. We believe that by enhancing the operational capabilities of life sciences firms, we can significantly contribute to advancing global health outcomes.
By 2030, Yendou will redefine industry benchmarks. We'll cut operational costs by 20% and reduce site activation time down to 4 months across all indications.
We're not just aiming for progress; we're setting a new standard for it.
Join us in shaping the future of Drug Development
Developing safe, secure and beneficial technology in healthcare requires people from a wide range of disciplines and backgrounds.